Tuesday, January 04, 2011
Rare Disease Day 2011: Focus health inequalities
28th February 2011 marks the 4th International Rare Disease Day coordinated by EURORDIS and rare disease national alliances in 25 countries.
Rare Disease Day is intended to increase awareness of rare diseases amongst the general public, European, national and local health authorities and policy makers, health professionals, researchers, academics, the pharmaceutical and biotech industries, as well as the media.
Hundreds of patient groups and their partners, coordinated by national alliances at the country level, will organise a multitude of events to draw attention to rare diseases and the millions of people who are affected by them. Awareness-raising activities are planned across Europe, all the way to Russia, Georgia and Armenia, as well as in the US, Canada and as far as Australia, New Zealand, China and Japan!
This year, EURORDIS member national alliances in 25 countries will combine their efforts to put the spotlight on 'rare diseases and health inequalities' and converge around the slogan “Rare but Equal”.
More specifically, in 2011, Rare Disease Day will seek to draw attention to the:
* Gaps in health that exist for rare disease patients between and within countries in the EU;
* Gaps in health that exist for rare disease patients compared with other segments of society.
The campaign will serve to advocate for:
* Equal access for rare disease patients to health care and social services;
* Equal access to basic social rights: health, education, employment, housing;
* Equal access to orphan drugs and treatments.
Patients, caregivers, social workers and doctors who have a story they would like to share are encouraged to contact the Rare Disease Day organisers at rarediseasedaystories2011@eurordis.org.
EURORDIS’ Council of National Alliances will meet in a week’s time to coordinate and plan the last details of this important event. If you would like to organise an awareness-raising activity you can still do so by contacting your national alliance or country organiser. To obtain their contact details go to www.rarediseaseday.org/national_alliance
If you are not a patient organisation or cannot see your country in the country page of the website, and would like to organise an activity or simply help relay the message to others, you can sign up as Friend of Rare Disease Day and add your name to a growing list of sympathisers on the website.
You can also join the more than 10,000 fans who have already signed up to Rare Disease Day Facebook, and send your video or photo (with commentary in your own language) to the RDD Flickr site and YouTube channel especially created for this day.
As you can see there are plenty of ways to get involved! Let’s combine our efforts to give hope to rare disease patients all over the world!
If you would like to find out more about this year’s campaign, go to www.rarediseaseday.org.
Source
http://www.eurordis.org/
Saturday, December 25, 2010
Sunday, November 28, 2010
European Strategy for Chronic Conditions – Second Workshop
Average health expenditure in the EU Member States is forecast to nearly double to 16% of GDP by 2020 due, in large part, to the costs of dealing with the impact of chronic conditions. Despite being largely preventable, chronic conditions are the cause of 86% of premature deaths in the WHO European Region and have significant economic implications.
Chronic conditions are not just a health issue – they impact on the workplace, the home environment, social support services and family networks – yet governments for the most part have been slow to integrate policies, inter-departmental budgets and service provision to suit the needs of patients and providers and facilitate the input of community and private expertise.
EPPOSI’s first workshop in 2008 identified the clear need for a Europe-wide strategy to ensure open, equal access to care and treatment for patients with chronic conditions, which is patient-centred and must recognise the often ignored role of carers. Now the challenge is how to turn that into reality.
Even without the ongoing effects of the financial crisis an inexorable rise in expenditure is unsustainable, so how can policy-makers, patients, healthcare providers and insurers, the pharmaceutical industry, social services and employers better work together to reduce the risks of chronic conditions, improve quality of life and confront the economic implications? Complex challenges call for innovative responses: EPPOSI invites all stakeholders to its Second Workshop on Chronic Conditions to help formulate the principal elements of a holistic new model which can actively reduce the debilitating personal and economic burden of chronic conditions. The model will be developed by a Task Force, to be set up after the workshop and based on its outcomes, which can be adapted and implemented in all Member States.
Sources
http://www.epposi.org/web/Home/Home.aspx
http://www.pharmanews.eu/conferences-and-events/688-a-european-strategy-for-chronic-conditions
Chronic conditions are not just a health issue – they impact on the workplace, the home environment, social support services and family networks – yet governments for the most part have been slow to integrate policies, inter-departmental budgets and service provision to suit the needs of patients and providers and facilitate the input of community and private expertise.
EPPOSI’s first workshop in 2008 identified the clear need for a Europe-wide strategy to ensure open, equal access to care and treatment for patients with chronic conditions, which is patient-centred and must recognise the often ignored role of carers. Now the challenge is how to turn that into reality.
Even without the ongoing effects of the financial crisis an inexorable rise in expenditure is unsustainable, so how can policy-makers, patients, healthcare providers and insurers, the pharmaceutical industry, social services and employers better work together to reduce the risks of chronic conditions, improve quality of life and confront the economic implications? Complex challenges call for innovative responses: EPPOSI invites all stakeholders to its Second Workshop on Chronic Conditions to help formulate the principal elements of a holistic new model which can actively reduce the debilitating personal and economic burden of chronic conditions. The model will be developed by a Task Force, to be set up after the workshop and based on its outcomes, which can be adapted and implemented in all Member States.
Sources
http://www.epposi.org/web/Home/Home.aspx
http://www.pharmanews.eu/conferences-and-events/688-a-european-strategy-for-chronic-conditions
Friday, November 19, 2010
The European Single Market –what’s in it for Hospital Pharmacists?
The European Commission has launched a public debate on a package of about 50 measures to revamp the Europe’s single market and stimulate economic growth and emploment.
The new “Single European Act” includes proposals to review EU rules in areas such as public procurement and mutual recognition of professional qualifications (MRPQ) which have direct implications for pharmacists.
The new “Single European Act” includes proposals to review EU rules in areas such as public procurement and mutual recognition of professional qualifications (MRPQ) which have direct implications for pharmacists.
For example, for pharmacists working in public hospitals and involved in the procurement of medicines, the review EU public procurement rules provides an opportunity to reflect on their experience in applying the rules and to make suggestions on how the process could be improved. The review of the MRPQ Directive offers an opportunity to reflect on the changing role of pharmacists and to consider whether the basic requirements for the recognition of professional qualifications are still up to date.
Although more in depth public consultations will be launched on any specific legislative proposals that go forward, the current debate is an opportunity to give some initial views on issues which are important for pharmacists. EAHP encourages you to share your views with us on the Single Market Act so that we can take a coordinated approach as European hospital pharmacists.
More information about the Single European Act along with an online submission form to contribute your views to the debate is available on the European Commission’s website.
The deadline for submitting views to the Commission is 28 February 2011.
The deadline for submitting views to the Commission is 28 February 2011.
Source
Thursday, October 28, 2010
ECDC publishes data on hepatitis B and C surveillance and prevention in Europe

ECDC releases today two new reports on hepatitis B and C entitled ‘Surveillance and prevention of hepatitis B and C in Europe’ and ‘Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies’.
Hepatitis surveillance is implemented in all Member States but varies considerably across countries. Universal vaccination programmes for HBV are implemented in 22 countries and seven countries have established targeted vaccination programmes.
The majority of the countries have implemented screenings for HBV in pregnant women; only four countries do not have such a programme. Half of the countries conduct screening programmes for hepatitis C, primarily for injecting drug users and prison inmates. Prevalence data on HBV and HCV remain scarce in many countries, both for the general population and groups-at-risk.
The release of the reports coincides with a summit conference on hepatitis B and C, which will take place from 14 to 15 October in Brussels, Belgium.
The conference will bring together major stakeholders to analyse new and existing information and enable European policy makers and other stakeholders to formulate public policies in response to the epidemic of viral hepatitis in Europe.
Download the report on Surveillance and prevention of hepatitis B and C in Europe
Download the report on hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies
Read the info sheet on hepatitis B and C: current situation in EU/EEA
Source
ECDC
Monday, October 11, 2010
European Commission Publishes Eurobarometer on Mental Health
A poll released to mark World Mental Health Day reveals that during the 12 months preceding the survey, 15% of respondents across EU Member States sought professional help for psychological or emotional problems and 7% took antidepressants, mostly for depression or anxiety.
This Eurobarometer survey on the self perceived Mental Health of European citizens was conducted during February and March 2010 in the 27 Member States of the European Union.
According to the results, there is still stigma attached to mental disorders, with 22% of those surveyed saying they would find it difficult to speak to a person with a "significant mental disorder". This issue and the other results will be discussed during the next thematic conference under the:
European Pact for Mental Health and Well-being : "Promoting Social Inclusion and Combating Stigma for better Mental Health and Well-being",
taking place in Lisbon on 8-9 November
Link to the Eurobarometer report: http://ec.europa.eu/health/mental_health/eurobarometers/index_en.htm
Source
http://ec.europa.eu/health/mental_health/eurobarometers/index_en.htm
Subscribe to:
Posts (Atom)



